Literature DB >> 18645371

Quantitative lacrimal scintigraphy in the assessment of epiphora.

James Jabbour1, Hans Van der Wall, Lysandra Katelaris, Julian Leslie, Douglas Mackey, Raf Ghabrial.   

Abstract

The transit of Tc-99m pertechnetate through 122 lacrimal drainage systems was quantified. Systems were categorized as having presac, preduct, intraduct, or no delay. Scintigraphy indicated an obstruction in 81.3% of eyes with epiphora. Of the 18 eyes in whom only scintigraphy revealed an obstruction, all 3 who underwent surgery experienced symptom relief. In patients presenting with unilateral epiphora the mean canthus half-time (12.9 vs. 7.2 minutes), time-to-peak activity at the sac (11.6 vs. 3.1 minute), and sac half-time (19.0 vs. 10.3 minutes) were significantly prolonged in the symptomatic eye. Similarly, the sac-to-canthus (0.32 vs. 0.72), duct-to-canthus (0.32 vs. 0.99), and duct-to-sac ratios (0.48 vs. 0.79) of peak activity were all significantly reduced in the symptomatic eye. When compared with "no delay," "presac," "preduct," and "intraduct" delay were significantly associated with attenuated clearance times or reduced ratios of peak activity corresponding to the level of obstruction. We conclude that there is a significant association between symptomatic epiphora and quantitative variables at the canthus and sac in lacrimal scintigraphy. Quantitative variables help locate the level of an obstruction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18645371     DOI: 10.1097/RLU.0b013e31817dea9c

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  The value of lacrimal scintillography in the assessment of patients with epiphora.

Authors:  O A Vonica; E Obi; Z Sipkova; C Soare; A R Pearson
Journal:  Eye (Lond)       Date:  2017-03-03       Impact factor: 3.775

2.  Clinical utility of SPECT/CT and CT-dacryocystography-enhanced dacryoscintigraphy in the imaging of lacrimal drainage system obstruction.

Authors:  Sandor Barna; Ildiko Garai; Kornel Kukuts; Rudolf Gesztelyi; Laszlo Toth; Adam Kemeny-Beke
Journal:  Ann Nucl Med       Date:  2019-07-16       Impact factor: 2.668

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.